- Home
- INDO vs ATRA Comparison
INDO vs ATRA Comparison
Compare INDO & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDO | ATRA |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | Indonesia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.2M | 38.9M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | INDO | ATRA |
|---|---|---|
| Price | $2.70 | $10.05 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 593.8K | ★ 3.2M |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.52 | $3.92 |
| 52 Week High | $8.50 | $19.15 |
Technical Indicators
Market Signals| Indicator | INDO | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 35.98 | 58.40 |
| Support Level | N/A | $4.35 |
| Resistance Level | $3.05 | $11.35 |
| Average True Range (ATR) | 0.16 | 0.82 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 8.40 | 49.64 |
Price Performance
Historical ComparisonAbout INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).